Depreciation of CNBX Pharmaceuticals Inc. from 31 Aug 2013 to 30 Nov 2025

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
CNBX Pharmaceuticals Inc. quarterly and annual Depreciation in USD history and change rate from 31 Aug 2013 to 30 Nov 2025.
  • CNBX Pharmaceuticals Inc. Depreciation for the quarter ending 30 Nov 2025 was $0.
  • CNBX Pharmaceuticals Inc. annual Depreciation for 2025 was $0, a 100% decline from 2024.
  • CNBX Pharmaceuticals Inc. annual Depreciation for 2024 was $72,320, a 55% decline from 2023.
  • CNBX Pharmaceuticals Inc. annual Depreciation for 2023 was $162,061, a 18% decline from 2022.
Source SEC data
View on sec.gov
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Change (%)
Depreciation, Annual (USD)
Depreciation, YoY Annual Change (%)

CNBX Pharmaceuticals Inc. Quarterly Depreciation (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $0 $0 01 Sep 2025 30 Nov 2025 10-Q 14 Jan 2026 2026 Q1
Q4 2024 $0 -$39,461 -100% 01 Sep 2024 30 Nov 2024 10-Q 14 Jan 2026 2026 Q1
Q4 2023 $39,461 -$3,724 -8.6% 01 Sep 2023 30 Nov 2023 10-Q 13 Jan 2025 2025 Q1
Q4 2022 $43,185 -$8,638 -17% 01 Sep 2022 30 Nov 2022 10-Q 12 Jan 2024 2024 Q1
Q4 2021 $51,823 -$5,682 -9.9% 01 Sep 2021 30 Nov 2021 10-Q 13 Jan 2023 2023 Q1
Q4 2020 $57,505 +$5,927 +11% 01 Sep 2020 30 Nov 2020 10-Q 13 Jan 2022 2022 Q1
Q4 2019 $51,578 +$5,078 +11% 01 Sep 2019 30 Nov 2019 10-Q 14 Jan 2021 2021 Q1
Q4 2018 $46,500 +$41,360 +805% 01 Sep 2018 30 Nov 2018 10-Q 14 Jan 2020 2020 Q1
Q4 2017 $5,140 +$4,871 +1811% 01 Sep 2017 30 Nov 2017 10-Q 17 Jan 2019 2019 Q1
Q4 2016 $269 -$146 -35% 01 Sep 2016 30 Nov 2016 10-Q 16 Jan 2018 2018 Q1
Q1 2016 $1,398 $415 +$47 +13% 01 Dec 2015 29 Feb 2016 10-Q 18 Apr 2016 2016 Q2
Q4 2015 $1,351 $415 +$47 +13% 01 Sep 2015 30 Nov 2015 10-Q 17 Jan 2017 2017 Q1
Q3 2015 $1,304 $201 +$115 +134% 01 Jun 2015 31 Aug 2015 10-K 13 Dec 2016 2016 FY
Q2 2015 $1,189 $367 +$367 01 Mar 2015 31 May 2015 10-Q/A 17 Nov 2015 2015 Q3
Q1 2015 $822 $368 +$368 01 Dec 2014 28 Feb 2015 10-Q 18 Apr 2016 2016 Q2
Q4 2014 $454 $368 +$368 01 Sep 2014 30 Nov 2014 10-Q/A 08 Apr 2016 2016 Q1
Q3 2014 $86 $86 01 Jun 2014 31 Aug 2014 10-K 07 Jan 2016 2015 FY
Q2 2014 $0 01 Mar 2014 31 May 2014 10-Q/A 17 Nov 2015 2015 Q3
Q1 2014 $0 01 Dec 2013 28 Feb 2014 10-Q/A 17 Nov 2015 2015 Q2
Q4 2013 $0 01 Sep 2013 30 Nov 2013 10-Q/A 17 Nov 2015 2015 Q1

CNBX Pharmaceuticals Inc. Annual Depreciation (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $0 -$72,320 -100% 01 Sep 2024 31 Aug 2025 10-K 01 Dec 2025 2025 FY
2024 $72,320 -$89,741 -55% 01 Sep 2023 31 Aug 2024 10-K 01 Dec 2025 2025 FY
2023 $162,061 -$36,466 -18% 01 Sep 2022 31 Aug 2023 10-K 29 Nov 2024 2024 FY
2022 $198,527 -$22,399 -10% 01 Sep 2021 31 Aug 2022 10-K 30 Nov 2023 2023 FY
2021 $220,926 +$5,771 +2.7% 01 Sep 2020 31 Aug 2021 10-K 30 Nov 2022 2022 FY
2020 $215,155 +$26,227 +14% 01 Sep 2019 31 Aug 2020 10-K 29 Nov 2021 2021 FY
2019 $188,928 +$100,488 +114% 01 Sep 2018 31 Aug 2019 10-K 04 Nov 2020 2020 FY
2018 $88,440 +$81,421 +1160% 01 Sep 2017 31 Aug 2018 10-K 29 Nov 2019 2019 FY
2017 $7,019 +$5,442 +345% 01 Sep 2016 31 Aug 2017 10-K 29 Nov 2018 2017 FY
2016 $1,577 +$273 +21% 01 Sep 2015 31 Aug 2016 10-K 08 Dec 2017 2017 FY
2015 $1,304 +$1,218 +1416% 01 Sep 2014 31 Aug 2015 10-K 13 Dec 2016 2016 FY
2014 $86 +$86 01 Sep 2013 31 Aug 2014 10-K 07 Jan 2016 2015 FY
2013 $0 01 Sep 2012 31 Aug 2013 10-K/A 23 Oct 2015 2014 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.